Announce Date | 02/20/2024 |
EPS Normalized Actual | $1.63 (Beat by $0.04) |
EPS GAAP Actual | $1.63 (Beat by $0.04) |
Revenue Actual | $1.351B |
Revenue Surprise | Beat by $1351M |
Announce Date | 04/30/2024 (Pre-Market) |
EPS Normalized Estimate | $1.40572 |
EPS GAAP Estimate | $1.40572 |
Revenue Estimate | $1.209794219B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Oct 2026 | 9.74 | 15.37 | 8.39 | 11.09 | 2 |
Oct 2025 | 8.24673 | 18.16 | 7.34346 | 9.57 | 5 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2022 (Apr 2022) | 1.41 | 1.41 | 1.351B | 9.62% | 1351M |
FQ1 2022 (Jan 2022) | 1.25 | 1.25 | 1.25B | 5.6% | 1250M |
FQ4 2021 (Oct 2021) | 1.54 | 1.54 | 1.294B | 5.72% | 1294M |
FQ3 2021 (Jul 2021) | 1.38 | 1.38 | 1.246B | 18.86% | 1246M |
FQ2 2021 (Apr 2021) | 1.01 | 1.01 | 1.221B | 26.7% | 1221M |
FQ1 2021 (Jan 2021) | 0.93 | 0.93 | 1.18B | 7.2% | 1180M |
FQ4 2020 (Oct 2020) | 1.16043 | 1.16043 | 1.22B | 8.2% | 1220M |
FQ3 2020 (Jul 2020) | 0.94 | 0.94 | 1.011B | -7.52% | 1011M |
FQ4 Announce Date
04/30/2024 (Pre-Market)
Consensus EPS Estimates
1.40572
Consensus Revenue Estimates
1.209794219B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 3.21 | -- | 3.18365 | 3.24723 | 5 |
FQ3 2026 (Jul 2026) | 2.79 | -- | 2.7671 | 2.82236 | 3 |
FQ2 2026 (Apr 2026) | 2.45 | -- | 2.42989 | 2.47842 | 5 |
FQ1 2026 (Jan 2026) | 2.36 | -- | 2.34063 | 2.38737 | 3 |
FQ4 2025 (Oct 2025) | 2.04286 | -- | 2.02609 | 2.06656 | 6 |
FQ3 2025 (Jul 2025) | 1.83714 | -- | 1.82206 | 1.85845 | 4 |
FQ2 2025 (Apr 2025) | 1.74286 | -- | 1.72855 | 1.76308 | 6 |
FQ1 2025 (Jan 2025) | 1.67705 | -- | 1.66328 | 1.6965 | 4 |
FQ4 2024 (Oct 2024) | 1.67403 | -- | 1.66029 | 1.69345 | 5 |
FQ3 2024 (Jul 2024) | 1.47521 | -- | 1.40448 | 1.53584 | 8 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 1.8B | -- | 1.79B | 1.81B | 6 |
FQ3 2026 (Jul 2026) | 1.67B | -- | 1.66B | 1.69B | 3 |
FQ2 2026 (Apr 2026) | 1.57B | -- | 1.56B | 1.59B | 3 |
FQ1 2026 (Jan 2026) | 1.5B | -- | 1.49B | 1.51B | 3 |
FQ4 2025 (Oct 2025) | 1.42B | -- | 1.41B | 1.43B | 2 |
FQ3 2025 (Jul 2025) | 1.32B | -- | 1.31B | 1.33B | 2 |
FQ2 2025 (Apr 2025) | 1.28B | -- | 1.27B | 1.29B | 3 |
FQ1 2025 (Jan 2025) | 1.26B | -- | 1.25B | 1.27B | 4 |
FQ4 2024 (Oct 2024) | 1.28B | -- | 1.28B | 1.3B | 5 |
FQ3 2024 (Jul 2024) | 1.22B | -- | 1.21B | 1.23B | 7 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2022 (Apr 2022) | 1.41 | 1.41 | 100% | |
FQ1 2022 (Jan 2022) | 1.25 | 1.25 | 100% | |
FQ4 2021 (Oct 2021) | 1.54 | 1.54 | 100% | |
FQ3 2021 (Jul 2021) | 1.38 | 1.38 | 100% | |
FQ2 2021 (Apr 2021) | 1.01 | 1.01 | 100% | |
FQ1 2021 (Jan 2021) | 0.93 | 0.93 | 100% | |
FQ4 2020 (Oct 2020) | 1.16043 | 1.16043 | 100% | |
FQ3 2020 (Jul 2020) | 0.94 | 0.94 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2022 (Apr 2022) | $0B | $1.35B | $1351M | 100% |
FQ1 2022 (Jan 2022) | $0B | $1.25B | $1250M | 100% |
FQ4 2021 (Oct 2021) | $0B | $1.29B | $1294M | 100% |
FQ3 2021 (Jul 2021) | $0B | $1.25B | $1246M | 100% |
FQ2 2021 (Apr 2021) | $0B | $1.22B | $1221M | 100% |
FQ1 2021 (Jan 2021) | $0B | $1.18B | $1180M | 100% |
FQ4 2020 (Oct 2020) | $0B | $1.22B | $1220M | 100% |
FQ3 2020 (Jul 2020) | $0B | $1.01B | $1011M | 100% |